登录 |  注册 |  忘记密码 |  购卡 |  公司首页
简体   繁體   English
首页 > Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae >[Toll-like receptor 4: the potential therapeutic target for neuropathic pain].

[Toll-like receptor 4: the potential therapeutic target for neuropathic pain].

    加入收藏夹      点击:9

Activation of microglia plays a vital role in the initiation and maintenance of specific neuropathic pain states. By activating microglia in central nervous system, Toll-like receptor 4 (TLR4) can promote the release of proinflammatory cytokines and neuroactive compounds, participate in the initiation and maintenance of neuropathic pain, and trigger the opiate side effects. Therefore, TLR4 may be a potential therapeutic target for neuropathic pain. Inhibition of TLR4 has shown some biological effects in neuropathic pain models and ibudilast (the TLR4 pathway-inhibiting agent) has been approved for for phase 2 clinical trials. This article briefly reviews the structure, function, and mechanism of TLR4 as well as the development of TLR4-targeted drugs.

作 者 Ze-jun, Jia(Department of Neurosurgery, Second Military Medical University, Shanghai, China.);Fei-xiang, Wu;Qing-hai, Huang;Jian-min, Liu
刊 名 Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae  2012年34卷2期 168-73页 
DOI号 10.3881/j.issn.1000-503X.2012.02.013

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他相关网站。

北京万方数据股份有限公司

万方数据电子出版社

关于我们  |   联系我们  |   网站地图  |   主要产品  |   主要服务

使用帮助  |   服务承诺  |   诚聘英才  |   友情链接  |   知识产权

客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

客服邮箱:yiyao@wanfangdata.com.cn

充值卡购卡热线:400-667-1808

互联网出版许可证 新出网证(京)字042号

互联网药品信息服务资格证书号:(京)-经营性-2011-0017

信息网络传播视听节目许可证

北京市公安局海淀分局备案号:110109081585

京ICP证010071号